# T32 Training Program in Mechanisms and Innovation in Vascular Disease

> **NIH NIH T32** · STANFORD UNIVERSITY · 2020 · $436,039

## Abstract

Project Summary
This T32 translational vascular research training program builds on the capabilities of the Stanford
Cardiovascular Institute, which provides valuable unique and innovative professional development opportunities
to a diverse group of promising early career investigators in vascular disease management. It supports NHLBI’s
mission to develop novel integrative strategies to prevent, diagnose, and treat cardiovascular diseases, while at
the same time fulfilling its educational goal to train tomorrow’s leaders in basic, translational, and applied vascular
research. This T32 is Stanford's only University-wide effort to develop the next generation of translational
vascular investigators. The program goals include rigorous training in the scientific method, critical analysis,
logical reasoning and independent thinking in a highly collaborative, multidisciplinary setting. Trainees develop
a focused area of vascular research expertise and are exposed to a wide range of complementary research
techniques. Mentors model collegial and productive collaboration provide guidance in oral and written
communication and instill respect for the responsible conduct of research. Our past trainees have gone on to
become independent researchers in premier academic institutions and in industry and are emerging leaders in
the field of vascular research.
The program proposes to continue training 6 postdoctoral fellows in multidisciplinary vascular research. Fellows
are appointed to this T32 annually, with a strong encouragement to seek their own funding for additional years
as part of the skills imparted by the program. 31 trainees so far have benefited from this program, including 18
women and 4 underrepresented minorities. Six are currently in training. Evaluations suggest a high degree of
satisfaction with the program. The Program is directed by Philip Tsao, PhD (Contact PI), Professor of Medicine,
Stanford University School of Medicine; Associate Chief of Staff -Precision Medicine, VA Palo Alto Health Care
System, and Nicholas Leeper, MD, Professor of Surgery and Medicine; Chief, Vascular Medicine, Stanford.
Administrative and program management support is provided by a dedicated team of educators in the Stanford
Cardiovascular Institute. An Internal Advisory Board consisting of senior Stanford faculty from a broad range of
disciplines and an External Advisory Board consisting of leading experts in vascular medicine and research in
the US play a vital role in monitoring the progress of this training program, providing ongoing support and advice
as needed. Our overarching goal is to train the next generation of investigators in vascular research, and
to facilitate their transition into productive and successful academic and industry leaders.

## Key facts

- **NIH application ID:** 10021162
- **Project number:** 2T32HL098049-11A1
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Nicholas James Leeper
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $436,039
- **Award type:** 2
- **Project period:** 2010-07-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10021162

## Citation

> US National Institutes of Health, RePORTER application 10021162, T32 Training Program in Mechanisms and Innovation in Vascular Disease (2T32HL098049-11A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10021162. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*